Saxenda is a GLP-1 receptor agonist licensed in the UK for weight management in adults with obesity or overweight with comorbidities Erectile dysfunction is not listed amongst known adverse effects in the Summary of Product Characteristics or clinical trial data Obesity itself is a well-established risk factor for erectile dysfunction through vascular, hormonal, and metabolic mechanisms Weight loss achieved with Saxenda may actually improve erectile function over time as metabolic health improves Common Saxenda side effects include gastrointestinal symptoms, which typically diminish over time and may indirectly affect sexual wellbeing Patients experiencing new sexual health concerns should consult their GP for thorough assessment rather than discontinuing treatment without medical guidance Table of Contents Understanding Saxenda and Its Primary Effects Saxenda (liraglutide 3.0 mg) is a prescription medicine licensed in the UK for weight management in adults with obesity or those who are overweight with weight-related health conditions

Individual outcomes depend heavily on dose escalation, adherence, caloric intake, and metabolic phenotype rather than a fixed weekly loss rate
Compounding is prohibited
Shexiang Baoxin Pill, a Traditional Chinese herbal formula, rescues the cognitive impairments in APP/PS1 transgenic mice
Frontiers in Pharmacology, 13, 1015045
Reading reviews and testimonials from other clients will also help you know more about the clinics services